Lamivudine And Zidovudine Tablet
Product Images NDC 71335-1916

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 71335-1916). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lami (Lamizido Lamivudine)

Chemical structure diagram of the active ingredients lamivudine and zidovudine, showing the molecular arrangement with nitrogen, oxygen, sulfur atoms, and hydroxyl group. The structure illustrates the stereochemistry and bond connections characteristic of these compounds.*

FDA Label Image

Zido (Lamizido Zidovudine)

Chemical structure diagram of the active ingredient Lamivudine and Zidovudine, showing molecular bonds and arrangement typical for these antiviral compounds.*

FDA Label Image

Label (Lbl713351916)

Packaging label for Lamivudine and Zidovudine 150 mg/300 mg tablets, labeled by Bryant Ranch Prepack. The label includes the NDC 71335-1916 and indicates the product compares to Combivir 150 mg/300 mg tablets by Macleods Pharmaceuticals Ltd. It specifies storage at room temperature 20°-25°C (68°-77°F) and to keep in a light-resistant container. The label also notes the product as Rx only with a lot number and barcode visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.